Sato, João Ricardo
Biazoli, Claudinei Eduardo Jr.
Salum, Giovanni Abrahão
Gadelha, Ary
Crossley, Nicolas
Vieira, Gilson
Zugman, André
Picon, Felipe Almeida
Pan, Pedro Mario
Hoexter, Marcelo Queiroz
Amaro, Edson Jr.
Anés, Mauricio
Moura, Luciana Monteiro
Del’Aquilla, Marco Antonio Gomes
Mcguire, Philip
Rohde, Luis Augusto
Miguel, Euripedes Constantino
Bressan, Rodrigo Affonseca
Jackowski, Andrea Parolin
Funding for this research was provided by:
FAPESP (2013/10498-6, 2013/00506-1, 2013/08531-5, 573974/2008-0)
Article History
Received: 4 September 2017
Accepted: 20 October 2018
First Online: 3 November 2018
Compliance with ethical standards
:
: Dr. Luis Augusto Rohde has been on the speakers’ bureau/advisory board and/or acted as a consultant for Eli-Lilly, Janssen-Cilag, Novartis, and Shire in the last 3 years. The ADHD and Juvenile Bipolar Disorder Outpatient programs chaired by Dr. Rhode have also received unrestricted educational and research support from the following pharmaceutical companies in the last 3 years: Eli-Lilly, Janssen-Cilag, Novartis, and Shire. Dr. Rohde has also received travel grants from Shire for participation in the 2014 American Physiological Association and 2015 World Federation of ADHD congresses. Finally, he receives authorship royalties from Oxford Press and ArtMed. Dr. Rodrigo Affonseca Bressan has been on the speakers’ bureau/advisory board of AstraZeneca, Bristol, Janssen, and Lundbeck. Dr. Bressan has also received research grants from Janssen, Eli-Lilly, Lundbeck, Novartis, Roche, FAPESP, CNPq, CAPES, Fundação E.J. Safra, and Fundação ABAHDS. He is also a shareholder in Biomolecular Technology Ltd. Dr. Edson Amaro Jr. has received research grants from FAPESP, CNPq, CAPES, Fundação E.J. Safra, and Fundação ABAHDS. Dr. Pedro Pan received a PhD Scholarship from CNPq.